Employee Stock Plans (Tables)
|
12 Months Ended |
Jan. 31, 2026 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Stock Option Activity |
A summary of stock option activity for the periods presented, is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Options Outstanding | | Number of Options | | Weighted Average Exercise Price | | Average Remaining Contractual Life (Years) | | Aggregate Intrinsic Value
(in thousands) | Balance as of January 31, 2024 | 6,121,268 | | $17.57 | | 6.09 | | $223,306 | | Granted | — | | n/a | | | | | | Exercised | (990,063) | | $6.98 | | | | | | Forfeited | (50,025) | | $10.97 | | | | | Balance as of January 31, 2025 | 5,081,180 | | $19.70 | | 5.22 | | $133,540 | | Granted | — | | n/a | | | | | | Exercised | (1,732,084) | | $9.16 | | | | | | Forfeited | (16,648) | | $34.64 | | | | | Balance as of January 31, 2026 | 3,332,448 | | $25.10 | | 4.69 | | $17,719 | Vested and expected to vest as of January 31, 2026 | 3,331,285 | | $25.10 | | 4.69 | | $17,719 | Exercisable - January 31, 2026 | 3,248,175 | | $24.85 | | 4.68 | | $17,719 |
| | | | | | | | | | | | | | | | | | | Fiscal Year Ended January 31, | | 2026 | | 2025 | | 2024 | | Aggregate intrinsic value of options exercised during each respective period (in millions) | $35.75 | | $34.97 | | $72.85 |
|
| Schedule of Summarized Unvested RSU Award Activity |
The following table summarizes unvested RSU and PSU award activity and related information:
| | | | | | | | | | | | | Shares | | Weighted-Average Grant Date Fair Value | Balance as of January 31, 2025 | 6,043,723 | | | | Granted | 5,590,648 | | $31.75 | | Replacement awards issued in connection with acquisition | 1,888,172 | | $36.52 | | Vested | (2,806,509) | | $38.34 | | Forfeited | (940,238) | | $38.22 | Balance as of January 31, 2026 | 9,775,796 | | |
|
| Schedule of Stock-Based Compensation Expense |
The following table summarizes stock-based compensation expense, which was included in the consolidated statements of operations as follows (in thousands): | | | | | | | | | | | | | | | | | | | Fiscal Year Ended January 31, | | 2026 | | 2025 | | 2024 | | Cost of revenue | $ | 4,829 | | | $ | 4,022 | | | $ | 3,585 | | | Sales and marketing | 44,017 | | | 38,168 | | | 31,198 | | | Research and development | 56,816 | | | 43,004 | | | 38,962 | | | General and administrative | 39,239 | | | 29,067 | | | 23,432 | | | Stock-based compensation, net of amounts capitalized | $ | 144,901 | | | $ | 114,261 | | | $ | 97,177 | | | Capitalized stock-based compensation expense | 2,073 | | | 2,259 | | | 2,152 | | | Total stock-based compensation expense | $ | 146,974 | | | $ | 116,520 | | | $ | 99,329 | |
|
| Schedule of Employee Service Share Based Compensation Unrecognized Compensation Costs |
As of January 31, 2026, total compensation cost not yet recognized related to unvested equity awards and the weighted-average remaining period over which these costs are expected to be realized were as follows: | | | | | | | | | | | | | Stock Options | | Restricted Stock, RSUs, PSUs | | Unrecognized compensation costs (in thousands) | $1,354 | | $218,621 | | Weighted-average remaining recognition period (years) | 0.49 | | 2.48 |
|